Επιπρόσθετη βιβλιογραφία για μελέτη
1. Adami, P.E., Koutlianos, N., Baggish, A., et al. (2022). Cardiovascular effects of doping substances, commonly prescribed medications and ergogenic aids in relation to sports: a position statement of the sport cardiology and exercise nucleus of the European Association of Preventive Cardiology. Eur J Prev Cardiol 29: 559–575, 2022. doi:10.1093/eurjpc/zwab198.
2. Deligiannis A, H. Björnstad, F. Carre, et al. ESC Study Group of Sports Cardiology Position Paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 13: 687-694, 2006.
3. Gurley BJ, Steelman SC, Thomas SL. Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy. Clin Ther 37: 275-301, 2015.
4. La Gerche A, Brosnan MJ. Cardiovascular Effects of Performance-Enhancing Drugs. Circulation 135: 89-99, 2017.
5. Maughan RJ, Burke LM, Dvorak J, et al. IOC consensus statement: dietary supplements and the high-performance athlete. Br J Sports Med 52: 439-55, 2018.
6. World Anti-Doping Code. WADA, 2021.
7. Prohibited List. WADA, 2022